Science
The Icelandic DNA Behind Amgen’s Hunt for the Next Ozempic
Key Points
The Icelandic DNA Behind Amgen’s Hunt for the Next Ozempic Amgen's best chance at breaking into the high-stakes obesity drug market got its start in a basement at the University of Iceland Science Park in Reykjavík, in a freezer chilled to minus-13 degrees Fahrenheit. Bloomberg's Madison Muller explains.
Nov 2nd, 2026
The Icelandic DNA Behind Amgen’s Hunt for the Next Ozempic
Amgen's best chance at breaking into the high-stakes obesity drug market got its start in a basement at the University of Iceland Science Park in Reykjavík, in a freezer chilled to minus-13 degrees Fahrenheit. Bloomberg's Madison Muller explains.